| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | Mission Produce stock initiated with buy rating at Freedom Capital | ||
| Do | Barclays reiterates Teva Pharma stock rating amid volatility | ||
| Do | Morgan Stanley reiterates Rivian stock Underweight on robotaxi deal | ||
| Do | Freedom Capital Markets initiates Trilogy Metals stock with buy rating on copper project potential | ||
| Do | Evercore ISI cuts Trade Desk stock price target on Publicis issues | ||
| Do | Northland reiterates Movado stock rating citing margin expansion path | ||
| Do | Evercore ISI cuts Accenture stock price target on valuation | ||
| Do | Accenture enhances Microsoft cybersecurity offering with AI agents | ||
| Do | AttoTude adopts Keysight signal analysis software for THz tech | ||
| Do | Two Harbors stock receives unsolicited $10.70 bid amid UWMC deal | ||
| Do | Cosmos Health plans guidance update following 2025 results | ||
| Do | Cairn Homes CEO to sell 0.6% stake via accelerated bookbuild | ||
| Do | US Tiger Securities upgrades Alibaba stock on AI momentum | ||
| Do | BNP Paribas Exane raises Five Below stock price target on strong sales | ||
| Do | Evercore ISI reiterates Outperform on Uber stock on Rivian deal | ||
| Do | Novo Nordisk wins FDA approval for higher-dose Wegovy injection | ||
| Do | SDCL Efficiency Income Trust declares 1.59p quarterly dividend | ||
| Do | Evercore ISI reiterates Outperform on Ferrari stock amid Middle East concerns | ||
| Do | Greensleeves Homes Trust completes £21.5m bond tender offer | ||
| Do | Gold Royalty Q4 2025 slides: record results mark 5-year milestone | ||
| Do | BofA reiterates Sarepta stock Underperform on regulatory risk | ||
| Do | Petrus Q4 2025 slides: Harmattan deal boosts liquids mix to 40% | ||
| Do | Atlas Metals director purchases 138,000 shares at 7.75p | ||
| Do | Jefferies reiterates Sarepta stock rating on regulatory pathway | ||
| Do | United Internet FY 2025 slides: EPS surges 43% amid network investment |